Literature DB >> 22696035

Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?

S M Marshall1.   

Abstract

This edition of Then and Now discusses three papers published in Diabetologia in the 1980s relating to diabetic nephropathy. Two epidemiological papers by Andersen et al (1983; 25:496-501) and Borch-Johnsen et al (1985; 28:590-596) described in graphic detail the ravages of diabetic nephropathy in type 1 diabetes. After 40 years of diabetes, 41% of their cohort had developed persistent proteinuria. The median time from first appearance of proteinuria to death was 7-8 years, the majority dying of uraemia or cardiovascular disease. The third paper, by Mathiesen et al (1984; 26:406-410), identified individuals with microalbuminuria, a much earlier stage of diabetic nephropathy, and analysed the risk of progression to persistent proteinuria at various levels of urine albumin excretion. Since the description of microalbuminuria, clinicians have hoped that earlier identification of individuals at high risk of end-stage kidney disease, coupled with aggressive use of reno-protective therapies, would prevent, or at the very least significantly delay, the development of end-stage renal disease. Recent data suggest that the outlook has indeed improved since the 1980s, at least in some populations. However, we may be delaying rather than preventing the development of microalbuminuria, proteinuria and kidney failure. Whilst a delay of 10 or more years in the appearance of end-stage renal disease is very welcome, further work is needed to understand why rates of chronic kidney disease vary substantially between cohorts and to develop novel therapies.

Entities:  

Mesh:

Year:  2012        PMID: 22696035     DOI: 10.1007/s00125-012-2606-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Authors:  Elizabeth T Rosolowsky; Jan Skupien; Adam M Smiles; Monika Niewczas; Bijan Roshan; Robert Stanton; John H Eckfeldt; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

2.  Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

Authors:  Peter Hovind; Lise Tarnow; Kasper Rossing; Peter Rossing; Stefanie Eising; Nicolai Larsen; Christian Binder; Hans-Henrik Parving
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

3.  Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

Authors:  Carol Forsblom; Valma Harjutsalo; Lena M Thorn; Johan Wadén; Nina Tolonen; Markku Saraheimo; Daniel Gordin; John L Moran; Merlin C Thomas; Per-Henrik Groop
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

4.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T J Orchard; A M Secrest; R G Miller; T Costacou
Journal:  Diabetologia       Date:  2010-07-28       Impact factor: 10.122

5.  Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.

Authors:  Trevor J Orchard; Yue-Fang Chang; Robert E Ferrell; Nancy Petro; Demetrius E Ellis
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

6.  The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Borch-Johnsen; P K Andersen; T Deckert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

7.  Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.

Authors:  Anne Sofie Astrup; Lise Tarnow; Peter Rossing; Lotte Pietraszek; Peter Riis Hansen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

8.  Incipient nephropathy in type 1 (insulin-dependent) diabetes.

Authors:  E R Mathiesen; B Oxenbøll; K Johansen; P A Svendsen; T Deckert
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

9.  Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

Authors:  P Rossing; P Hougaard; K Borch-Johnsen; H H Parving
Journal:  BMJ       Date:  1996-09-28

10.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

View more
  24 in total

Review 1.  Early diabetic nephropathy in type 1 diabetes: new insights.

Authors:  Petter Bjornstad; David Cherney; David M Maahs
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243

2.  Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011.

Authors:  Miira M Klemetti; Hannele Laivuori; Minna Tikkanen; Mika Nuutila; Vilho Hiilesmaa; Kari Teramo
Journal:  Diabetologia       Date:  2015-01-10       Impact factor: 10.122

3.  Risk Factors for Kidney Disease in Type 1 Diabetes.

Authors:  Bruce A Perkins; Ionut Bebu; Ian H de Boer; Mark Molitch; William Tamborlane; Gayle Lorenzi; William Herman; Neil H White; Rodica Pop-Busui; Andrew D Paterson; Trevor Orchard; Catherine Cowie; John M Lachin
Journal:  Diabetes Care       Date:  2019-03-04       Impact factor: 19.112

Review 4.  Genetics of diabetic nephropathy: a long road of discovery.

Authors:  Amy Jayne McKnight; Seamus Duffy; Alexander P Maxwell
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 5.  Insulin sensitivity and complications in type 1 diabetes: New insights.

Authors:  Petter Bjornstad; Janet K Snell-Bergeon; Kristen J Nadeau; David M Maahs
Journal:  World J Diabetes       Date:  2015-02-15

Review 6.  Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?

Authors:  Petter Bjornstad; Kim C Donaghue; David M Maahs
Journal:  Lancet Diabetes Endocrinol       Date:  2018-02-20       Impact factor: 32.069

7.  Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Authors:  Julie A Lovshin; Geneviève Boulet; Yuliya Lytvyn; Leif E Lovblom; Petter Bjornstad; Mohammed A Farooqi; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Zi Cherney
Journal:  JCI Insight       Date:  2018-01-11

8.  Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.

Authors:  Petter Bjornstad; David M Maahs
Journal:  Curr Pediatr Rep       Date:  2015-04-04

Review 9.  Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study.

Authors:  David M Maahs; Luiza Caramori; David Z I Cherney; Andrzej T Galecki; Chuanyun Gao; Diana Jalal; Bruce A Perkins; Rodica Pop-Busui; Peter Rossing; Michael Mauer; Alessandro Doria
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

10.  Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes.

Authors:  P Bjornstad; D M Maahs; R J Johnson; M Rewers; J K Snell-Bergeon
Journal:  Diabet Med       Date:  2014-10-10       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.